One platform for therapeutic plasma exchange (TPE) and selective removal of:
- LDL cholesterol and lipoprotein(a)
- fibrin, fibrinogen, and fibrin degradation products
The TheraSorb™ Therapeutic Apheresis system is based on the selective removal of pathogenic substances from the patient’s plasma.
During apheresis, target molecules are selectively removed while the plasma is reinfused into the patient. Hence, higher plasma volumes can be processed than in therapeutic plasma exchange. Since no substitution fluid is required, the treatment is usually very well tolerated.
TheraSorb Products may be helpful for the treatment of diseases associated with hypercholesterolemia, pathogenic immunoglobulins, and fibrinogen.